However, for environmental or occupational toxicants only aggregated data are usually available, so toxicokinetic analyses typically ignore population variability. We propose a hierarchical Bayesian approach to estimate inter-individual variability from the observed mean and variance at each time point, using a bivariate normal (or lognormal) approximation to their joint likelihood. Through analysis of both simulated data and real toxicokinetic data from 1,3-butadiene exposures, we conclude that given information on the form of the individual-level model, useful information on inter-individual variability may be obtainable from aggregated data, but that additional sensitivity and * Weihsueh A. Chiu is Environmental Health Scientist,
INTRODUCTION
Population analyses of toxicokinetic data are designed to characterize inter-individual variability in the parameters or predictions of models describing the absorption, distribution, metabolism, and excretion of toxicants in the body. While such analyses are standard in pharmaceutical research (Sheiner, and Covington et al. 2007 ). Population analysis methods such as non-linear mixed effects or hierarchical Bayesian modeling require individual-level data. However, individual data from toxicokinetic studies (commonly performed in laboratory animals, but also sometimes in humans) are often unavailable due to the common practice of summarizing data in the form of average and SD (which are sufficient for some classical analyses).
Toxicokinetic analyses of older, often under-exploited, datasets therefore typically ignore population variability because models are fit using reported means and standard errors from multiple individuals, with those parameters interpreted as representing an "average individual." The increasing use of physiologically-based toxicokinetic (PBTK) models, which have many more parameters than classical pharmacokinetic models, has led to the additional practice of fixing "known" physiological variables and estimating the remaining chemical-specific parameters either from in vitro measurements or by "fitting" to aggregated data. There are several problems with such practices. First, except for the simplest models, the concept of "average" parameters is difficult to interpret because of the non-linear relationships between model parameteres and predictions. Moreover, the general presumption that population variability can be ignored in laboratory animal experiments because they are performed on groups of in-bread, genetically similar strains is questionable. Such data still may show a fairly wide range of kinetic response, especially evident in experiments that report single data points for individual animals (e.g., Prout, Provan, and Green 1985) . Furthermore, there is typically a large amount of both uncertainty and variability in parameters in PBTK models that are treated as "known," and the selection of which parameters to fix and which to fit is difficult, especially when combining information from various sources and multiple datasets. Therefore, the practice of fitting to aggregate data in this setting can at the very least underestimate overall uncertainty and may lead to inaccurate and biased estimates We demonstrate here that population inferences may still be made from aggregated data if both the observed mean and variance at each time point are available and there is a priori information about the model and variance structures. In particular, we propose that the usual hierarchical Bayesian approach, briefly reviewed in Section 2, be extended by treating individual data as missing (or latent) and marginalizing over it. As described in Section 3, we approximate the corresponding (generally intractable) joint likelihood of the observed means and variances with a multivariate normal (or lognormal) distribution having the correct first and second-order moments. The form of the likelihood depends in part on the underlying measurement model for the individual data and the assumed variance structure. We derive approximations based on normal, proportional, and lognormal errors and a single level of inter-individual variability, which are commonly used in toxicokinetic models. In Section 4, we present comparisons of analyses based on individual data using the full population approach to analyses based on aggregated data using our proposed approximations for three simulated data sets and one published human toxicokinetic dataset of controlled exposures to 1,3-butadiene. We find in our examples that the aggregated analyses provide posterior predictions quite similar to individual analyses, albeit with greater posterior uncertainty, as should be expected. In Section 5, we discuss our conclusion that substantial information on inter-individual variability may remain in the aggregated data, and that such information can be recovered through appropriate analyses. Given that some information is still lost in data aggregation, we suggest that posterior analyses, including checking of model fit, sensitivity, and parameter identifiability, are of great importance to increasing confidence in conclusions drawn from analyses of aggregated data.
POPULATION MODELING OF TOXICOKINETICS
As described in Gelman et al. (1996) , population modeling of toxicokinetics involves setting up a model in several stages. A nonlinear toxicokinetic model, with predictions denoted f , describes the absorption, distribution, metabolism, and excretion of a compound and its metabolites in the body. This model depends on several, usually known, parameters such as measurement times t, exposure E, and measured covariates φ. Each subject i in a population has a set of unknown parameters θ i . A population model describes their distribution in the population, and incorporates existing scientific knowledge about them through prior distributions on the population mean µ and variance Σ 2 . Finally, a "measurement error" model describes deviations ǫ (with variance σ 2 ) between the data y and model predictions f . This level of the hierarchical model typically also encompasses intraindividual variability as well as model misspecification, but for notational convenience we refer to it here as "measurement error." All these components are illustrated graphically in the left part of Figure   1 .
*** Figure 1 about here.
The posterior distribution for the unknown parameters is obtained in the usual manner by multiplying (A) the prior distribution for the population mean and variance and the "measurement" error P (µ, Σ 2 |I)P (σ 2 |I), (B) the population distribution for the indi-4 vidual parameters P (θ|µ, Σ 2 , I), and (C) the likelihood P (y|θ, σ 2 , I), where for notational convenience, we collapse the knowledge of f , φ, E, t, and n into prior information I:
Here, each individual's parameters θ i have the same sampling distribution (i.e., they are iid ), so their joint prior distribution is
We consider three different measurement models for the likelihood function, normal errors (Model I), proportional errors (Model II), and lognormal errors (Model III), as shown in Table 1 . Note that Models II and III are heteroscedastic, a common concern for toxicokinetic data. Different types of measurements j = 1 . . . m may have different errors, but errors are otherwise assumed to be iid. Since the individuals are treated as independent given θ 1...n , the total likelihood function is simply
where n is the number of individuals and m is the number of different types of measurements, N j is the number of measurements of type j, and t jk are the times at which measurements of type j were made. Note we have assumed that the individuals each have the same experimental design, as would be expected if data were to be aggregated.
ANALYSIS OF AGGREGATED DATA
If individual data have been aggregated, and one only has the number of individuals n and the sample mean m jk and variance s 2 jk of individual measurements at time-point k, then one must modify the statistical model used. The individual data y ijk are considered missing or latent, and therefore treated as parameters rather than data in a Bayesian context. Thus, the standard data model becomes part of the population model, and a new data model for m and s 2 is needed. One therefore has a posterior distribution given by The approach we take is to marginalize over the individual measured values y ijk , which here may be considered nuisance parameters, prior to sampling via Monte Carlo. The posterior distribution we are aiming for, then, has the form
with
This marginalization is illustrated graphically on the right part of Figure 1 . Because the
) is conditional on θ, it is independent of the population model for inter-individual variability and only depends on the "measurement" model.
Below, we present approximations to P (m, s 2 |θ, σ 2 , I) for the different measurement models considered above. Note that from here on we generally suppress the indices j, k for clarity, and concentrate on approximations for the integral in equation (7).
Likelihood Functions for Various Measurement Models
Our general approach is to approximate (for fixed observation type j and time-point t k ) the The derivation for lognormal errors, Model III, merits additional discussion. In this case, the mean, given by m = (1/n) f i exp(ǫ i ), has no simple closed form solution for its distribution (see Barakat 1976 and Leipnik 1991 for series approaches to calculating the characteristic function). Several approaches may be taken to approximate it. For large n and/or small σ 2 , the central limit theorem can be invoked to approximate the distribution for m by a normal distribution. For many applications, however, n is quite small (∼ 4), and Barakat (1976) shows that the coefficient of skewness of the sum distribution decays only
Moreover, m and √ s 2 are often of the same order, so it may be important to incorporate the fact that m must be positive. For these reasons, in many telecommunications and engineering applications, the sum of lognormal deviates is commonly approximated by a lognormal distribution by matching moments (e.g., Fenton 1960 So as to enable use of the same approach, we take as our second "observed" value not the variance s 2 but the second moment
as it is also a sum of lognormal deviates. Thus, we also approximate its distribution by a lognormal distribution by matching moments, noting that it is the same form as m with σ 2 → 4σ 2 and then the above formula can sometimes give a value of r > 1. In this case, however, we have found that using the above formula, but taking σ → 0 (i.e., the limit in which measurement error is negligible relative to inter-individual variability), so that r
gives reasonable results. We take the minimum value of r from the above two formulae as the one we use in our distribution for m and m 2 , as shown in Table 1 . We find that this approach sometimes slightly underestimates r by up to a few percent, but ensures that r ≤ 1.
This constraint on r should be checked in posterior simulations.
Additional Issues for Consideration

Sufficiency and Identifiability
For most non-linear models, there will undoubtedly be some loss of information in data aggregation, so there may be concerns about whether there is still sufficient information to ensure parameter identifiability in the toxicokinetic and population models. However, even with individual data, a toxicokinetic model may not be fully identifiable (e.g., the estimation of decay times of a mixture of exponentials is ill-conditioned, Acton 1970), so this problem is not unique to aggregated data. At the very least, some a priori information on the system being analyzed should exist to motivate the formulation of the model and, preferably, informative prior distributions for its parameters. For instance, in their analysis of tetrachloroethylene toxicokinetics, Gelman et al. (1996) remarked that both the physiological model and prior distributions were necessary to ensure identifiability. At best, data from other experiments 8 where data were not aggregated could be used to establish the appropriate model form. In toxicokinetics, if one's goal is to characterize population variability, then one presumably already has sufficient information to justify the structure of the individual-level model. So we focus in particular on parameter identifiability rather than model discrimination.
For non-linear models, these issues are necessarily case-specific, and it may not be possible to know whether parameter identifiability is a problem prior to performing an analysis.
However, posterior and sensitivity analyses can be done to check that the population parameters are identifiable given the data. The first evidence for non-sufficiency would be if the priors and posterior distributions are identical. If the posteriors are narrower, then the data add some information. A scalar measure τ of the "overlap" between marginal prior and posterior distributions was proposed by Garrett and Zeger (2000) for latent class models, and is adapted here for more general use. In particular, for a parameter θ, data y, and prior information I, prior distribution P (θ|I), and posterior distribution P (θ|y, I), the "overlap diagnostic" is defined as In particular, performing PCA on the posterior samples, and then comparing the posterior distributions of the principal components with their priors (i.e., applying the same centering, scaling, and rotation to samples from their joint prior distribution) should identify any nondiagonal components which are not identifiable. This should also be applicable to cases such as y i (t) = θ i + ǫ it , where variance contributions from different levels of the hierarchical model are indistinguishable after data aggregation.
Choice of Measurement Model
In standard population analyses, the choice of measurement model is influenced only by the underlying hypothesis for how the individual data deviate from model predictions. In our case, how the data are aggregated also plays a role. For most toxicokinetic data, a lognormal measurement model has been traditionally assumed for individual data points.
One could thus either use Model I by transforming y → ln y, or use Model III. A priori, Model I would be preferable because it is simpler. However, one could only use this model if the aggregation was done on the transformed data -e.g., the reported values are geometric mean and standard deviation. Typically, it is the arithmetic mean and standard deviation that are reported, so that model III would be the most appropriate. Unfortunately, model III is also the least robust of the models because of the requirement for σ 2 ≤ 0.5 and the possible lack of stability of the derived correlation coefficient. Model II then is a more robust alternative approximation that still allows for errors to be proportional to the measured value.
On a practical matter, data are probably most useful in a regime where proportional normal errors (Model II) and lognormal errors (Model III) are not easily distinguishable. Moreover, the measurement model also encompasses model misspecification, and a value of σ > 0.5 (i.e., a > 50% error) may be reason to rethink the model.
Model Checking and Model Choice
As with standard population analyses, model checking is important here. In addition to the identifiability checks described above, the most basic check is whether the model is consistent with the data. In the standard population analysis, a typical method to perform this check is to compare simulated (replicated) data y i,rep with the observed data y i,obs (Gelman, One important limitation of aggregated analyses, however, is that the structural assumptions in the population model P (θ|µΣ 2 ) and the measurement model P (y|θ, σ 2 ), which are not easy to check with individual data, are even more difficult to validate with only aggregated data. Typical techniques for assessing these assumptions include both posterior simulations as well as sensitivity analyses. For aggregated analyses, posterior simulation is of somewhat limited usefulness when checking structural assumptions because of the additional layer of latency. Sensitivity analyses take on greater importance. We illustrate this below by considering all three measurement models in our analyses.
On the related issue of model choice, there are a large number of statistical methods for model selection in both a frequentist (e.g., log-likelihood ratio test, Akaike information criterion) and Bayesian context (e.g., Bayes factors, Bayesian information criterion). These methods may be less reliable with only aggregated data. Fortunately, the formulation of toxicokinetic models is motivated primarily by a priori biological and chemical information rather than statistical measures.
In checking and choosing models, it is also important to make a distinction between the "statistical" and "practical" significance of model errors. That is, because models such as those used in toxicokinetics can never be thought of as strictly "true," statistical lack of fit may or may not have an impact on the substantive inferences for which the model is used.
Thus, the use of the model should be kept in mind when assessing either the consistency between model predictions and data or the impact of different model assumptions.
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APPLICATION TO DATA ON 1,3-BUTADIENE
We first performed a number of simulations with a simple model and simulated data, as summarized in Table 2 . These simulations covered all three measurement models. We generated simulated data and compared full population analysis of the individual data with analyses of the same data aggregated. Computations were performed using WinBUGS ver- were generated. This offered support for the accuracy of the approach developed here.
*** Table 2 about here.
Butadiene data and model
We then applied our aggregation model to actual toxicokinetic data. The data and model are described in detail in Bois, Smith, Gelman, Chang, and Smith (1999), and are summarized briefly here. Eight human volunteers were recruited and tested at National Cheng Kung University in Taiwan. The tests were conducted, under informed consent, with an
Institutional Review Board-approved human subjects protocol. They were exposed to an ambient concentration C in (t) of five ppm of 1,3-butadiene for two hours and then zero thereafter. This exposure was the minimum that could be precisely measured, and was well below Taiwan's allowable occupational exposure of 10 ppm per eight hour work day for a working lifetime. For each individual, measurements of body weight (BDW ), minute-ventilation rate K in , and blood-air partition coefficients P ba were made along with exhaled breath measurements C ex (t k ) at a series of times t k from the beginning of exposure to about one hour post-exposure. The full dataset for C ex (t k ) is displayed in all three panels of 
where, in addition to the parameters defined above, P ca is the central-to-air partition coefficient (assumed to be the measured blood-air partition coefficient P ba ); K cp is the rate constant for distribution from central to peripheral compartments; P pc is the peripheral to central partition coefficient; and K met is the metabolic rate constant. The measurement of covariates BDW , K in , and P ba greatly improves parameter identifiability in this model.
The exhaled concentration at observed time t k is given by
where a physiological dead space of 30% is assumed. Because the product P pc V p is not separable, it is treated as a single parameter to ensure identifiability. In addition, the central volume and the minute-volume are assumed to follow the scaling relations To summarize, each individual i has seven parameters θ i = (sc V c , K cp , P pc V p , K met , P ca , sc K in , BDW ) i and four types of observations y i = (P ba,obs , K in,obs , C ex,obs (t k ), BDW obs ) i .
All errors were assumed lognormal except for BDW , for which errors were assumed to be normal:
where in the middle two cases, the model predictions are given by equations (13) and (11), respectively, and ǫ Pca ∼ N (0, log 1.17), ǫ K in ∼ N (0, log 1.02), ǫ Cex ∼ N (0, log GSD ex ), and ǫ BDW ∼ N (0, 0.25 kg) (the first two were based on replicate samples).
Data aggregation was performed using log-transformed measurements (thus using Error Model I) as well as un-transformed measurements (thus using Error Models II and III), the last of which are also shown in the left panel of Figure 2 . Simulations for all cases were performed using the MCSim software. To ensure consistency, the original MCSim code used in Bois et al. (1999) was obtained and modified only where needed.
Prior distributions were the same as in Bois et al. (1999) , except for the body weight parameters, which are new. The prior mean body weight was assigned a uniform distribution with min and max equal to the min and max measured body weight. The prior variance was assigned the inverse Gamma distribution with shape parameter of unity and scale parameter corresponding to a 20% coefficient of variation. All priors are listed in Table 3 . As was done in Bois et al. (1999) , 50,000 iterations performed for two independent chains in each case. The first 10,000 iterations were discarded, and only every 10 iterations were stored for analysis. Convergence was monitored through the method of Gelman and Rubin (1992), and potential scale reduction factors were ≤ 1.03 in the case of individual data, and ≤ 1.01 in the aggregated data cases.
Comparisons between full population and aggregated analyses
*** Figure 3 and Table 3 about here. Table 3 and Figure 3 summarize the statistical results for both full population and aggregated analyses. There is substantial agreement between the different analyses, as shown visually in Figure 3 . Posterior estimates of all population parameters substantially overlap for all parameters except for the "measurement" error, which is signficantly larger in the aggregated analyses (discussed below). While difficult to see in the Figure due to the logarithmic scale, estimates of the population mean parameters (µ), summarized in Table 3 , are not greatly affected by the use of aggregated data, both in terms location and scale. In most cases, the population variances (expressed as geometric standard deviations exp Σ in Table   3 ) are only slightly affected as well, with 95% confidence intervals substantially overlapping among the four analyses. The uncertainties in the population variance parameters exp Σ, however, are consistently greater in the aggregated analyses. Because the inverse-Gamma priors on the population variances Σ 2 have shape parameter of unity, they have infinite dispersion. Thus, greater posterior uncertainty generally leads to higher central estimates and upper confidence limits. This is reflected in the results, particularly for parameters sc V c and sc K in . It is clear that in these cases, some information was lost in the aggregation process. The parameter for "measurement" error GSD ex was slightly greater in the aggregated analyses. Bois et al. (1999) reported that the analytical errors were estimated to be about 7%, so this increased "measurement" error reflects additional model error (e.g., due
to the approximations necessary to derive the likelihood functions) and/or intraindividual variability. Table 3 
Parameter identifiability
Checks for non-identifiability were conducted on the full population analysis as well as each aggregated analysis, concentrating on the 15 population parameters (mean and variance for each of the 7 model parameters, plus residual "measurement" variance). Given the narrowing of all of these distributions from prior to posterior, one would not expect any parameters to be completely unidentifiable. Indeed, for population means, values for the overlap diagnostic Further checks examined whether some parameter combinations are only weakly constrained by the data. As a visual check, the correlation matrix was calculated with mean parameters log-transformed (this is more "natural" since the population model and most of the likelihoods are lognormal) and variability parameters transformed, if necessary, to variances (e.g., GSD → (ln GSD) 2 ). All non-diagonal correlation coefficients for the population parameters were in the interval (-0.4,0.6); of the 15 × 14/2 = 105 unique non-diagonal elements, only 8 were outside the interval [-0.2,0.2]. Thus, there were some correlations, but none were extremely strong.
PCA was performed on the posteriors with the R statistical package, with centering to zero mean and scaling to unit variance (i.e., equivalent to determining the eigenvectors of the correlation matrix). Each analysis (full population and the three aggregated) had a slightly different rotation matrix, as should be expected for a non-linear model and the approximate likelihood functions used. Priors for each set of principal components were then generated by applying the same transformations to random samples from the joint prior distribution. All prior principal component [2.5%,97.5%] confidence intervals included zero (which, by definition, is the posterior mean of the principal components), so there is no conflict between priors and posteriors even after transformation. Moreover, the posterior confidence intervals were wholly contained within the prior confidence intervals, with the prior intervals substantially wider (i.e., by at least 5.9-fold). Thus, we conclude that there are no substantial parameter identifiability problems.
Checking Model Fit
Inspection of Figure 2 (middle and right panel) of the scatter in the data points relative to the scatter of the predictions suggests that full population and aggregated analyses give similar inter-individual variance in their predictions. Additional checks using the full posterior distribution of predictions for the measured mean and variance for the exhaled air concentration C ex showed good qualitative consistency between the model predictions and the underlying (aggregated) data (not shown). However, the scatter during the period of exposure (t = 0 − 120 minutes) appears underestimated, perhaps due to intraindividual variability, which here was not modeled separately but lumped with "measurement" error. This feature also appears in the full population analysis, as can be seen in the middle panel of Figure 2 . We also note that, for Model III, the posterior range of the "measurement" error variance σ < 0.5, as required by our approximation for the likelihood function. In addition,
for Model III, we checked the approximation for the correlation parameter r, and found that in no case did the moment-matching formula give r > 1, so the σ → 0 approximation was never used.
Sensitivity analysis is illustrated through comparison of the results from different error models. Summary statistics are quite similar, with the exception of the variance of sc V c , which had greater uncertainty in Model II. In particular, the posterior estimates for the dose metric AMET were remarkably consistent. Furthermore, graphs of the posterior distributions as well as the comparisons between data and model predictions showed little sensitivity to different error models (not shown).
Finally, we note that checks for parameter identifiability ( §4.3), model fit and sensitivity analyses are not unique to the analysis of aggregated data. They could (and should, in our opinion) be more widely applied to standard population analyses as well. For instance, parameter identifiability is usually not checked in any formal manner. Model fit is typically checked only through scatter plots of data and a single posterior prediction (e.g., using a "random sample" or using population mean parameters), as is shown in Figure 2 . As reported above, we performed additional checks using the full posterior distribution. Checking of the assumed "measurement" error model, as was done here as part of the sensitivity analyses, is rarely done. We have not yet applied our approach to more complex (e.g., PBTK) models, but results from the butadiene example are encouraging.
DISCUSSION
There are several important limitations to our approach, some of which are fundamental and some more practical. First of all, in the examples we have examined, the assumption On a practical level, the analysis of aggregated data is more computationally burdensome than if individual data were available. This is due to the more complicated likelihoods, particularly for Models II and III where there is covariance, and possibly slower convergence.
For instance, on an Intel Pentium 4 2.8 GHz processor running Windows XP with 512 MB of RAM, two chains of length 50,000 run in MCSim took about 1 hour to complete for the individual data for butadiene, and about 4.5 hours for the aggregated data using Model III. While these times are not long, more complicated models and data could substantially increase the computation time and the chain length necessary for convergence. These practical limitations could be alleviated by either more efficient MCMC algorithms or faster computing power than we have used here.
Ideally, of course, individual data would always be available for analysis, and it is sound practice to use all such data. It should not be inferred from our analysis that summary data should be used when individual data are available, as data aggregation always entails a degree of information loss. However, especially in a toxicological/environmental health setting where data are often gathered from multiple, usually historical, sources, the original data may be unavailable. The effort, then, should be to maximize the use of the available information, particular in the case of human data where unnecessary exposure to toxicants should be minimized. Typically, no attempt is made to extract population variability information from aggregated data, perhaps because it is presumed to be unimportant or to have been lost in the aggregation process. Our analysis shows this information is not necessarily completely lost -that when both the mean and variance are reported, significant information on population variability may remain. We have presented here an example of application to the analysis of toxicokinetic data, but aggregation of data for publication has been pervasive in biology, and occasions to test the approach we propose should be plentiful. For example, in cancer bioassays, groups of animals are exposed to predetermined doses of a carcinogen and the onset of tumors is observed. Each animal is expected to react differently to the exposure. Such inter-individual variability can be studied if time-to-event reporting of tumors is available. given by ln κ 1,2 ∼ N (µ 1,2 , Σ 1,2 ), and measurement error models Error Parameter Individual analyses used error model III (Bois et al. 1999 ). Aggregated analyses for error model I used log-transformed measurements; those for error models II and III used untransformed measurements. Prior distributions on µ and Σ 2 are specified below, as are the posterior median 97.5%
2.5% on µ and exp Σ based on two independent chains of 50,000 iterations, thinned by 10, with the first 10,000 iterations discarded. For the prediction AMET, GM 8 and I-III (solid circle, triangle, and diamond, respectively).
